Early clinical observations in the fungal meningitis outbreak

A new article being published early online in Annals of Internal Medicine describes the diagnosis and treatment protocol established in a Roanoke, Va. hospital to care for dozens of patients presenting with suspected fungal meningitis related to contaminated epidural spinal injections. This unprecedented surge of patients seeking care for a rare central nervous system (CNS) infection required physicians to react quickly with little data to guide treatment decisions. The authors suggest that the data collected from these cases may fill information gaps and inform current and future therapy for fungal meningitis patients.

Since early October, nearly 400 people nationwide have been diagnosed with linked to contaminated injectable preservative-free methylprednisolone acetate used for epidural steroid injections and more than 14,000 people have been exposed. Currently, there are no clear recommendations for treatment. The Carilion Clinic in Roanoke saw half the fungal meningitis cases reported from Virginia and documented the clinical course.

The hospital established a hotline for patients concerned about infection. One-hundred-sixty-four patients presented to the emergency room and 133 met their exposure criteria for fungal meningitis due to the contaminated . After screening using lumbar punctures, 25 patients were diagnosed with fungal meningitis and were managed by Infectious Diseases services, which continually sent data on these patients to the . An additional two patients presented to the hospital moribund following stroke, died, and were diagnosed with fungal meningitis retrospectively.

All patients were treated with IV voriconazole at a dosage of 6 mg/kg every 12 hours and continued on this treatment, unless switched to IV amphotericin-B (if symptoms or side-effects warranted). Patients remained hospitalized until oral was available for home therapy, and continue to be seen weekly in a pop-up "fungal meningitis clinic" within the Infectious Disease outpatient clinic.

Roanoke clinicians still have questions about the nature and course of this infection. There were two patients who had symptoms of infection, but had an initial negative screening result at lumbar puncture. They returned later with meningitis, suggesting that patients will need to be followed for an undetermined duration of time. Two other patients presented with stroke and quickly died, while three other patients developed stroke during treatment, leading researchers to suspect that Exserohilum is angio-invasive. Finally, the high number of patients complaining of "word searching" suggests that long-term neurological consequences should be a concern.

The authors of an accompanying commentary acknowledge the risks associated with diagnosis and treatment of this rare CNS infection. The authors note some of the pressing questions physicians face when patients present with exposure or suspected infection. With limited knowledge of this infection, clinicians must rely on quickly evolving practice recommendations being established by the CDC and others gaining first-hand experience with this outbreak. The CDC has convened a committee of "Clinical Mycology Expert Consultants" that will consult on these cases. In the meantime, they will continue to capture data to inform recommendations.

add to favorites email to friend print save as pdf

Related Stories

Fungal meningitis deaths rise to 24, CDC reports

Oct 25, 2012

The U.S. Centers for Disease Control and Prevention reported Wednesday that a 24th person had died of fungal meningitis after receiving contaminated steroid injections. The latest victim had received an injection to treat ...

New insight on managing fungal meningitis

Oct 24, 2012

As the number of fungal meningitis cases continues to rise, physicians across the country are faced with how best to provide the early treatment that can save lives.

US warns meningitis cases could rise

Oct 12, 2012

US authorities have managed to contact most of the thousands of people exposed to the tainted drug blamed for a meningitis outbreak that has killed 14, but warned the number of infections could rise.

US: Pharmacy's other drugs may be causing illness

Oct 15, 2012

Two more drugs from a specialty pharmacy linked to a meningitis outbreak are now being investigated, U.S. health officials said, as they urged doctors to contact patients who got any kind of injection from the company.

What we know and don't know about fungal meningitis outbreak

Oct 18, 2012

In a new perspective piece being published Online First tonight in Annals of Internal Medicine, a physician recalls lessons learned from treating patients affected by the 2002 outbreak of Exophiala (Wangiella) dermatitidis meningi ...

Recommended for you

Sierra Leone: WHO too slow to help doc with Ebola

5 hours ago

Sierra Leone accused the World Health Organization on Monday of being "sluggish" in facilitating an evacuation of a doctor who died from Ebola before she could be sent out of the country for medical care.

Dutch doctors feared to have Ebola leave hospital

6 hours ago

Two Dutch doctors flown home from west Africa after fears they might have been contaminated with the killer Ebola virus have left hospital "in good health," their employer, the Lion Heart Medical Centre, said Monday.

Strategic self-sabotage? MRSA inhibits its own growth

11 hours ago

Scientists at the University of Western Ontario have uncovered a bacterial mystery. Against all logic, the most predominant strain of methicillin-resistant Staphylococcus aureus (MRSA) in North American produces an enzyme ...

US works to step up Ebola aid, but is it enough?

13 hours ago

The American strategy on Ebola is two-pronged: Step up desperately needed aid to West Africa and, in an unusual step, train U.S. doctors and nurses for volunteer duty in the outbreak zone. At home, the goal ...

User comments